We have previously shown that thyroid cancer patients can be divided into two cohorts based on the level of PCBP1 mRNA expression [11] and that in the cohort with high PCBP1 mRNA expression, PCBP1 protein expression is suppressed by degradation [11]. This evidence concerns the gene PCBP1 and thyroid gland carcinoma.